MarketWatch (press release) The awards program recognizes high- growth entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Dr. Nader joined NPS in 2006 ... and more »
News-Medical.net Please can you give an introduction to the epidermal growth factor receptor (EGFR) and outline what was previously known about drug resistant brain tumors? In cancer, mutations in proteins that control cell growth are common, leading to unrestrained ...
Huffington Post The study, published in the journal Cancer Causes & Control, is based on data from 634 people in Sweden who were all breast cancer patients; about half of them took the breast cancer drug Tamoxifen. ... that "something" is -- interacts with caffeine to ... and more »
MarketWatch (press release) The awards program recognizes high- growth entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Dr. Nader joined NPS in 2006 ... and more »
Businessweek The biggest factor was a sharp decline in pump prices for gasoline–down 8.1 percent in April after a 4.4 percent decline in March. But what was even more remarkable was a 0.1 percent decline in the price of medical care services. April was the first ...
Thomson Reuters News & Insight Over the past decade, growth came easily to the industry as blockbuster drugs like cholesterol-lowering Lipitor lost patent protection. But the expiration wave is ebbing, leading analysts to predict that the sector's revenue growth will hover around 5 ... and more »
Reuters UK An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to preliminary trial data released on Wednesday. * An ... and more »
Chicago Business Journal ... Food and Drug Administration. The companies said Tarceva once-daily tablets has been approved for the treatment of advanced-stage non-sm...
News-Medical.net Please can you give an introduction to the epidermal growth factor receptor (EGFR) and outline what was previously known about drug resistant brain tumors? In cancer, mutations in proteins that control cell growth are common, leading to unrestrained ...
Sacramento Bee Vectibix was approved in the United States in September 2006 as a single agent for the treatment of metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine, oxaliplatin and irinotecan chemotherapy regimens. Approval is ... and more »
